Old Web
English
Sign In
Acemap
>
authorDetail
>
Tongtong An
Tongtong An
Central South University
Oncology
Medicine
Internal medicine
non-small cell lung cancer (NSCLC)
EGFR inhibitors
2
Papers
23
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous Non‒Small-Cell Lung Cancer
2018
Journal of Clinical Oncology
Shun Lu
Jianhua Chang
Xiaoqing Liu
Jianhua Shi
You Lu
Wei Li
Jin-Ji Yang
Jianying Zhou
Jie Wang
Tongtong An
L. Yang
Zhe Liu
Xiangdong Zhou
Mo Chen
Ye Hua
Weiguo Su
Show All
Source
Cite
Save
Citations (17)
MA16.06 Phase I/II Study of AC0010, Mutant-Selective EGFR Inhibitor, in Non-Small Cell Lung Cancer (NSCLC) Patients with EGFR T790M Mutation
2017
Journal of Thoracic Oncology
Yi-Long Wu
Qing Zhou
Xiaoqing Liu
Li Zhang
Jianying Zhou
Lin Wu
Tongtong An
Ying Cheng
Xin Zheng
Bei Hu
Ji Jiang
Xin Fang
Wanhong Xu
Xiao Xu
Show All
Source
Cite
Save
Citations (6)
1